Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. 2017

Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
Pathology and Laboratory Medicine Institute, Clinical Microbiology Section, Cleveland Clinic Abu Dhabi, Al-Maryah Island, Abu Dhabi, United Arab Emirates. Electronic address: Alatooa@clevelandclinicabudhabi.ae.

OBJECTIVE This study compared the activity of ceftolozane-tazobactam and ceftazidime-avibactam against 120 bacterial strains, including extended-spectrum beta-lactamase (ESBL) producers, carbapenem-resistant Enterobacteriaceae (CRE), and Pseudomonas aeruginosa, isolated from patients admitted to Cleveland Clinic Abu Dhabi, United Arab Emirates. METHODS In vitro susceptibility was tested using the Etest strip minimum inhibitory concentration (MIC) method, and PCR was used to characterize the carbapenemase enzymes produced by CRE strains. RESULTS All 29 ESBL isolates were susceptible to ceftazidime-avibactam (MIC50 0.125μg/ml), whereas all but one were susceptible to ceftolozane-tazobactam (MIC50 0.38μg/ml). Twenty-seven (45%) CRE isolates were susceptible to ceftazidime-avibactam (MIC50 ≥256μg/ml), whereas only six (10%) isolates were susceptible to ceftolozane-tazobactam (MIC50 ≥256μg/ml). Very few NDM-1 isolates were susceptible to ceftazidime-avibactam, whereas the majority of OXA-48 isolates were susceptible. Twenty-nine (94%) P. aeruginosa isolates were susceptible to ceftazidime-avibactam (MIC50 1.5μg/ml), whereas 30 (97%) isolates were susceptible to ceftolozane-tazobactam (MIC50 0.75μg/ml). CONCLUSIONS Ceftolozane-tazobactam and ceftazidime-avibactam showed comparable activity against ESBL and P. aeruginosa, with ceftazidime-avibactam having lower MICs against ESBL isolates and ceftolozane-tazobactam having lower MICs against P. aeruginosa. Ceftazidime-avibactam showed better activity against all CRE isolates except for those carrying the NDM-1 enzyme.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078142 Tazobactam A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria. Tazobactam Sodium,YTR 830,YTR 830H,YTR-830,YTR830

Related Publications

Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
April 2023, Microbial drug resistance (Larchmont, N.Y.),
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
December 2017, Antimicrobial agents and chemotherapy,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
January 2020, Access microbiology,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
October 2022, Microbiology spectrum,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
March 2021, Microbial drug resistance (Larchmont, N.Y.),
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
May 2016, Antimicrobial agents and chemotherapy,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
March 2020, Acta microbiologica et immunologica Hungarica,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
February 2023, Microbiology spectrum,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
September 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Adnan Alatoom, and Hashim Elsayed, and Karen Lawlor, and Laila AbdelWareth, and Rania El-Lababidi, and Lysettee Cardona, and Mohammad Mooty, and Maria-Fernanda Bonilla, and Ahmad Nusair, and Imran Mirza
August 2023, Pathology,
Copied contents to your clipboard!